Saccharo is a biotech start-up in the immuno-oncology space in hot pursuit of a novel disease target discovered serendipitously — often the most disruptive type of discovery — by its scientific founder. Combining an exceptionally experienced, knowledgeable and well connected team with a lean virtual business model the company is uniquely positioned to develop therapeutics and diagnostics for cancer and other immune-shielding applications.